Down syndrome as risk factor for respiratory syncytial virus hospitalization: A prospective multicenter epidemiological study.

No Thumbnail Available

Date

2016-12-30

Authors

Sánchez-Luna, Manuel
Medrano, Constancio
Lirio, Julián
RISK-21 Study Group

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Respiratory syncytial virus (RSV) infection in childhood, particularly in premature infants, is associated with significant morbidity and mortality. To compare the hospitalization rates due to RSV infection and severity of disease between infants with and without Down syndrome (DS) born at term and without other associated risk factors for severe RSV infection. In a prospective multicentre epidemiological study, 93 infants were included in the DS cohort and 68 matched by sex and data of birth (±1 week) and were followed up to 1 year of age and during a complete RSV season. The hospitalization rate for all acute respiratory infection was significantly higher in the DS cohort than in the non-DS cohort (44.1% vs 7.7%, P Infants with DS showed a higher rate of hospitalization due to acute lower respiratory tract infection and RSV infection compared to non-DS infants. Including DS infants in recommendations for immunoprophylaxis of RSV disease should be considered.

Description

MeSH Terms

Acute Disease
Antiviral Agents
Down Syndrome
Epidemiologic Studies
Female
Follow-Up Studies
Hospitalization
Humans
Infant
Infant, Newborn
Male
Palivizumab
Prospective Studies
Respiratory Syncytial Virus Infections
Respiratory Syncytial Virus, Human
Risk Factors

DeCS Terms

CIE Terms

Keywords

Down syndrome, hospitalization, palivizumab, prospective birth cohort study, respiratory syncytial virus

Citation